-
effectivehealthcare-admin.ahrq.gov/products/mental-health-pregnancy/protocol
January 01, 2020 - low APGAR, withdrawal, respiratory distress, neonatal intensive care unit time, persistent pulmonary hypertension … Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. … Obstetric Labor, Premature"[Mesh] OR "Persistent Fetal Circulation Syndrome"[Mesh] OR "Persistent Pulmonary Hypertension
-
effectivehealthcare-admin.ahrq.gov/products/depression-postpartum-screening/research
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/products/chronic-urinary-retention/research
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/for-the-disabled-and-elderly-with-multiple-comorbidities-what-is-the-comparative-effectiveness-of-physician-housecalls-on-outcomes-and-total-cost
November 01, 2017 - in 2008)
Arthritis and nontraumatic joint disorders Cardiovascular disease, including stroke and hypertension
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_surveillance.pdf
June 01, 2012 - Signals
Renal Artery Stenting
Three independent predictors of
BP response:
4) Requirement for ≥4
hypertension … Strategy:
--------------------------------------------------------------------------------
1 exp Hypertension … - Conclusions: Renal artery stenting initially
improves hypertension control, but the
durability
-
effectivehealthcare-admin.ahrq.gov/products/ankyloglossia/research
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-241-physical-activity-wheelchair-evidence-summary-updated.pdf
October 01, 2021 - on the prevention of cardiovascular conditions (e.g., myocardial infarction, stroke,
development of hypertension
-
effectivehealthcare-admin.ahrq.gov/products/vitamin-d-calcium/research
December 01, 2019 - possible U-shaped association between serum 25(OH)D concentrations and both all-cause mortality and hypertension
-
effectivehealthcare-admin.ahrq.gov/products/mental-health-pregnancy/research
March 01, 2022 - spontaneous abortion, and child outcomes such as respiratory issues, low Apgar scores, persistent pulmonary hypertension
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/sleep-apnea_executive.pdf
July 01, 2011 - Adverse clinical outcomes associated with
OSA include: cardiovascular disease,
hypertension, non-insulin-dependent … index,
existing non-insulin-dependent diabetes mellitus,
existing cardiovascular disease, existing
hypertension … index, existing non-insulin-dependent diabetes
mellitus, existing cardiovascular disease, existing
hypertension … The two studies of cardiovascular mortality did not
have consistent findings, and the two studies of
hypertension … to
(continued) uncertain conclusions regarding the possible association between
AHI and incident hypertension
-
effectivehealthcare-admin.ahrq.gov/products/infantile-hemangioma/policymaker
December 01, 2019 - short lived--included Cushingoid facies, irritability/mood changes, abdominal pain, growth retardation, hypertension
-
effectivehealthcare-admin.ahrq.gov/products/congestive-heart-failure-medicines/research
January 01, 2020 - No therapy, except hypertension control, has been shown to reduce mortality from diastolic HF. 20 , 21 … Cardiac arrhythmias
28.1%
24
<.0001
Peripheral vascular disorder
13.6%
20
<.0001
Hypertension … (uncomplicated)
73.7%
84
<.0001
Hypertension (complicated)
8.5%
18
<.0001
Diabetes
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - positive results n fecal occult blood
test; class III/IV angina or
uncontrolled CHF, uncontrolled
hypertension … Low: ≤ 200
mg
High: >20
mg
Low: ≤ 25
mg
High: > 25
mg
Nonspecific
NSAID
NR New onset
hypertension … One study of
rofecoxib v diclofenac reported withdrawal due to CV events (hypertension: 3/231, palpitation … Other reported AEs include oedema (v
diclofenac, RR 19.20 CIL 1.17, 314.55), hypertension (v diclofenac … Other discontinuations for hypertension (2/471 v 0/473; RR
5.02 CI: 0.24, 104.31) and oedema (3/471
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb_surveillance.pdf
July 06, 2015 - pattern of symptoms), dose of the ACE inhibitor or ARB used, comorbidities (diabetes, renal dysfunction,
hypertension … Candesartan-based therapy and risk of cancer in patients with systemic hypertension (Heart Institute … of
symptoms), dose of the ACE inhibitor or ARB used, comorbidities (diabetes, renal dysfunction,
hypertension … of
symptoms), dose of the ACE inhibitor or ARB used, co-morbidities (diabetes, renal dysfunction, hypertension … of
symptoms), dose of the ACE inhibitor or ARB used, co-morbidities (diabetes, renal dysfunction, hypertension
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s29.pdf
October 01, 2007 - calcium-channel blockers, were widely
believed to be a more effective initial therapy than thiazides
for hypertension … as amlodipine, a
calcium channel blocker, or lisinopril, an ACE inhibitor, for
initial therapy for hypertension … vignettes, except that some subjects noted the
existence of effective, relatively low cost treatments for
hypertension
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/allergy-seasonal_executive.pdf
July 01, 2013 - Systemic adverse effects of decongestants may include
hypertension, tachycardia, insomnia, headaches … used with caution, if
at all, in patients with diabetes mellitus, ischemic heart
disease, unstable hypertension … contraindicated with coadministered
monoamine oxidase inhibitors and in patients with
uncontrolled hypertension … pregnancy, in children,
and in those whose treatment choices are restricted due to
comorbidities, such as hypertension … Nosebleeds
Nasal
Discomfort
Bitter
Aftertaste
Burning
Anxiety
Insomnia
Palpitations
Dryness
Hypertension
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_clinician.pdf
July 01, 2017 - major adverse cardiac events (MACE), all-cause death, sudden
cardiac death, revascularization, or high … blood pressure (BP). … conducted in
populations at increased risk for CVD (e.g., with diabetes,
cardiometabolic syndrome, hypertension
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
January 01, 2013 - Omega-3 fatty acids+fenofibrate:
Incidence of hypertension among
participants with high triglyceride … Vitamin E+furosemide: no significant
effect on BP in pts. with essential
hypertension
Vitamin E+nifedipine … (960 screened);
Inclusion criteria: 40-80 yrs
of age; controlled or absent
cholesterolemia and
hypertension … Omega-3 fatty acids+fenofibrate: Incidence of hypertension
among participants with high triglyceride … with essential hypertension
Vitamin E+nifedipine significant decrease in total cholesterol,
LDL-C,
-
effectivehealthcare-admin.ahrq.gov/products/breastfeeding-health-outcomes/research
March 01, 2025 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/opioids-oa-protocol.pdf
June 29, 2019 - analgesics (e.g., non-steroidal anti-inflammatory drugs) due to
impaired liver or kidney function, hypertension … Hypertension.
2004;43(3):573-577.
24. Whelton A, Fort JG, Puma JA, Normandin D, et al.